000 | 01643 a2200553 4500 | ||
---|---|---|---|
005 | 20250513193212.0 | ||
264 | 0 | _c20000111 | |
008 | 200001s 0 0 eng d | ||
022 | _a0390-6078 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTàssies, D | |
245 | 0 | 0 |
_aHepatitis G virus infection markers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacs. _h[electronic resource] |
260 |
_bHaematologica _cOct 1999 |
||
300 |
_a930-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlaviviridae |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHIV Antibodies _xblood |
650 | 0 | 4 |
_aHIV Infections _xetiology |
650 | 0 | 4 |
_aHemophilia A _xblood |
650 | 0 | 4 |
_aHepatitis, Viral, Human _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphocyte Subsets _xvirology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRNA, Viral _xblood |
650 | 0 | 4 |
_aSpain _xepidemiology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aViral Envelope Proteins _ximmunology |
700 | 1 | _aMagallón, M | |
700 | 1 | _aQuintana, M | |
700 | 1 | _aFernández-Urgellés, R P | |
700 | 1 | _aRodriguez-Pinto, C | |
700 | 1 | _aTusell, J | |
700 | 1 | _aAltisent, C | |
700 | 1 | _aReverter, J C | |
700 | 1 | _aMazzara, R | |
700 | 1 | _aOrdinas, A | |
700 | 1 | _aMonteagudo, J | |
773 | 0 |
_tHaematologica _gvol. 84 _gno. 10 _gp. 930-6 |
|
999 |
_c10466109 _d10466109 |